chrX-136669502-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_004840.3(ARHGEF6):c.2170G>A(p.Glu724Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000911 in 1,207,740 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000091 ( 0 hom. 3 hem. )
Consequence
ARHGEF6
NM_004840.3 missense
NM_004840.3 missense
Scores
6
5
6
Clinical Significance
Conservation
PhyloP100: 5.23
Genes affected
ARHGEF6 (HGNC:685): (Rac/Cdc42 guanine nucleotide exchange factor 6) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein belongs to a family of cytoplasmic proteins that activate the Ras-like family of Rho proteins by exchanging bound GDP for GTP. It may form a complex with G proteins and stimulate Rho-dependent signals. This protein is activated by PI3-kinase. Mutations in this gene can cause X-chromosomal non-specific cognitive disability. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 3 XL gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF6 | ENST00000250617.7 | c.2170G>A | p.Glu724Lys | missense_variant | 21/22 | 1 | NM_004840.3 | ENSP00000250617.6 | ||
ARHGEF6 | ENST00000370622.5 | c.1708G>A | p.Glu570Lys | missense_variant | 20/21 | 1 | ENSP00000359656.1 | |||
ARHGEF6 | ENST00000370620.5 | c.1708G>A | p.Glu570Lys | missense_variant | 20/21 | 2 | ENSP00000359654.1 |
Frequencies
GnomAD3 genomes AF: 0.00000895 AC: 1AN: 111672Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33896
GnomAD3 genomes
AF:
AC:
1
AN:
111672
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33896
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183356Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67824
GnomAD3 exomes
AF:
AC:
2
AN:
183356
Hom.:
AF XY:
AC XY:
0
AN XY:
67824
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000912 AC: 10AN: 1096068Hom.: 0 Cov.: 28 AF XY: 0.00000830 AC XY: 3AN XY: 361514
GnomAD4 exome
AF:
AC:
10
AN:
1096068
Hom.:
Cov.:
28
AF XY:
AC XY:
3
AN XY:
361514
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000895 AC: 1AN: 111672Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33896
GnomAD4 genome
AF:
AC:
1
AN:
111672
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33896
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 21, 2016 | The E724K variant in the ARHGEF6 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The E724K variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The E724K variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. As an alternate mechanism, multiple in silico algorithms predict that c.2170G>A (aka E724K) might create a cryptic donor site in intron 21 which may supplant the natural donor site. We interpret E724K as a variant of uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
.;.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Benign
T;T;T
Polyphen
0.99
.;.;D
Vest4
MVP
MPC
0.49
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at